Who owns CABA?
Institutional ownership of Cabaletta Bio Inc. from Form 13F, Q2 2026
140 institutional managers reported holding Cabaletta Bio Inc. (CABA) in Form 13F filings for Q2 2026, with 158,671,745 shares worth $493M. The largest reported holder was Jennison Associates LLC. Managers that filed both quarters added a net 73,995,574 shares (+87.4%). 55 opened new positions and 23 sold out.
- Funds holding
- 140
- Value held
- $493M
- New / sold out
- 55 / 23
- Net shares, same filers
- +87.4%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of CABA
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Jennison Associates LLC | $62.3M | 12.6% | 20,033,730 | Added |
| T. Rowe Price Investment Management, Inc. | $58.7M | 11.9% | 18,869,907 | Added |
| Bain Capital Life Sciences Investors, LLC | $53.6M | 10.9% | 17,241,445 | Added |
| BlackRock, Inc. | $33.4M | 6.8% | 10,754,701 | Added |
| Adage Capital Partners GP, L.l.c. | $28.5M | 5.8% | 9,174,758 | Added |
| State Street Corp | $24.4M | 4.9% | 7,839,305 | Added |
| Vanguard Capital Management LLC | $22.5M | 4.6% | 7,227,018 | Added |
| Cormorant Asset Management, LP | $15.6M | 3.2% | 5,000,000 | Trimmed |
| Price T Rowe Associates Inc | $13.7M | 2.8% | 4,418,674 | Added |
| Woodline Partners LP | $13.1M | 2.6% | 4,200,142 | Added |
| Norges Bank | $12.8M | 2.6% | 4,112,401 | New |
| Opaleye Management Inc. | $12.0M | 2.4% | 3,863,800 | Added |
| Citadel Advisors LLC | $11.0M | 2.2% | 3,522,112 | New |
| Geode Capital Management, LLC | $10.8M | 2.2% | 3,459,464 | Added |
| Franklin Resources Inc | $7.5M | 1.5% | 2,413,937 | New |
| Goldman Sachs Group Inc | $6.9M | 1.4% | 2,211,825 | Added |
| Millennium Management LLC | $6.4M | 1.3% | 2,068,491 | Trimmed |
| Cantor Fitzgerald, L. P. | $5.0M | 1.0% | 1,600,002 | Added |
| Marshall Wace, LLP | $4.9M | 1.0% | 1,565,939 | Trimmed |
| Renaissance Technologies LLC | $4.8M | 1.0% | 1,535,300 | Trimmed |
| UBS Group AG | $4.6M | 0.9% | 1,471,895 | Added |
| Qube Research & Technologies Ltd | $4.4M | 0.9% | 1,426,840 | Trimmed |
| Vanguard Portfolio Management LLC | $4.4M | 0.9% | 1,418,108 | New |
| Two Sigma Investments, LP | $4.4M | 0.9% | 1,410,931 | Trimmed |
| Morgan Stanley | $4.2M | 0.8% | 1,345,526 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 158,671,745 CABA shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Jennison Associates LLC Added+$34.4M
- BlackRock, Inc. Added+$26.1M
- T. Rowe Price Investment Management, Inc. Added+$24.2M
- Bain Capital Life Sciences Investors, LLC Added+$23.5M
- State Street Corp Added+$22.9M
- Norges Bank New+$12.8M
- Price T Rowe Associates Inc Added+$12.4M
- Citadel Advisors LLC New+$11.0M
- Vanguard Capital Management LLC Added+$9.9M
- Woodline Partners LP Added+$9.2M
Biggest sellers in Q2 2026
- Millennium Management LLC Trimmed-$11.9M
- Two Sigma Investments, LP Trimmed-$3.4M
- Marshall Wace, LLP Trimmed-$1.9M
- Qube Research & Technologies Ltd Trimmed-$1.6M
- Renaissance Technologies LLC Trimmed-$1.6M
- Cormorant Asset Management, LP Trimmed-$1.6M
- Jane Street Group, LLC Sold out-$669K
- Point72 Asset Management, L.P. Sold out-$663K
- Almitas Capital LLC Trimmed-$658K
- Ikarian Capital, LLC Trimmed-$622K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $260M and sold $29.8M; 50 added and 20 trimmed.
Schedule 13D and 13G filings on CABA
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-08-12NORGES BANK SCHEDULE 13G filed by Cabaletta Bio Inc.Schedule 13G
- 2026-07-27BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2026-02-18MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by Cabaletta Bio Inc.Schedule 13G
- 2025-08-14Alyeska Investment Group, L.P. SCHEDULE 13G filed by Cabaletta Bio Inc.Schedule 13G
- 2025-08-14Cormorant Asset Management, LP SCHEDULE 13G filed by Cabaletta Bio Inc.Schedule 13G
- 2025-06-20CITADEL ADVISORS LLC SCHEDULE 13G filed by Cabaletta Bio Inc.Schedule 13G
Questions about CABA ownership
- Who owns CABA stock?
- 140 institutional investment managers reported CABA positions in their Form 13F filings for Q2 2026, holding 158,671,745 shares worth $493M in total. Jennison Associates LLC reported the largest position.
- Are funds buying or selling CABA?
- In Q2 2026, 55 managers opened new CABA positions, 50 added, 20 trimmed and 23 sold out. Managers that filed in both quarters added a net 73,995,574 shares.
- How current is this CABA institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to CABA by CUSIP. Options are left out. CABA news and filings · CABA insider trades · Top funds